Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 818452

Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b


Bošnjak Pašić, Marija; Hajnšek, Sanja; Panajatović, Miljenko; Vidrih, Branka; Bohaček, Ivan; Miškov, Snježana
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b // Journal of the neurological sciences, 363 (2016), 145-146 (međunarodna recenzija, kratko priopcenje, znanstveni)


CROSBI ID: 818452 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b

Autori
Bošnjak Pašić, Marija ; Hajnšek, Sanja ; Panajatović, Miljenko ; Vidrih, Branka ; Bohaček, Ivan ; Miškov, Snježana

Izvornik
Journal of the neurological sciences (0022-510X) 363 (2016); 145-146

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, znanstveni

Ključne riječi
Liposarcoma ; Multiple sclerosis ; Interferon beta

Sažetak
Patient self-reporting of adverse events is alternative approach and could provide valuable information. Data obtained from patients could be sometimes different from physicians but they are complementary, each providing clinically meaningful information. In this article we present a patient who has been suffering from multiple sclerosis, treated by Interferon Beta -1b (IFNB-1b) over the past 10 years. This self reported case of liposarcoma is suspected to be related to the concurrent treatment with IFNB-1b opens numerous questions. On the basis of data available yet, we cannot conclude that the use of IFNB - 1b is related with the occurrence of malign disease in this case, but our effort to communicate these concerns with the patient resulted in continuation of our co-operation with the patient and his willingness to continue with the same immunomodulatory agent. Relationship with patients based on mutual appreciation is crucial for compliance and prevention of future relapses of MS.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinički bolnički centar Zagreb


Citiraj ovu publikaciju

Bošnjak Pašić, Marija; Hajnšek, Sanja; Panajatović, Miljenko; Vidrih, Branka; Bohaček, Ivan; Miškov, Snježana
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b // Journal of the neurological sciences, 363 (2016), 145-146 (međunarodna recenzija, kratko priopcenje, znanstveni)
Bošnjak Pašić, M., Hajnšek, S., Panajatović, M., Vidrih, B., Bohaček, I. & Miškov, S. (2016) Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b. Journal of the neurological sciences, 363, 145-146.
@article{article, year = {2016}, pages = {145-146}, keywords = {Liposarcoma, Multiple sclerosis, Interferon beta}, journal = {Journal of the neurological sciences}, volume = {363}, issn = {0022-510X}, title = {Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b}, keyword = {Liposarcoma, Multiple sclerosis, Interferon beta} }
@article{article, year = {2016}, pages = {145-146}, keywords = {Liposarcoma, Multiple sclerosis, Interferon beta}, journal = {Journal of the neurological sciences}, volume = {363}, issn = {0022-510X}, title = {Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b}, keyword = {Liposarcoma, Multiple sclerosis, Interferon beta} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font